Novartis and GlaxoSmithKline have agreed a multibillion dollar swap of assets under which the two pharmaceutical companies will join forces in the consumer healthcare sector combining brands including Aquafresh, Beechams and Tixylix and exchange their oncology and vaccine businesses.
Showing posts with label pharmaceutical companies. Show all posts
Showing posts with label pharmaceutical companies. Show all posts
April 18, 2014
GlaxoSmithKline says it is investigating bribery claims in Jordan and Lebanon
GlaxoSmithKline, the UK's largest drug firm, is investigating claims that its staff in Jordan and Lebanon have bribed doctors.
February 07, 2011
Europe, US “using fake drugs crisis to boost pharma profits”
The proliferation of substandard, dangerous medicines in poor countries is being used by rich nations as an excuse to tighten intellectual property (IP) rules, boosting the profits of large pharmaceutical companies while making it harder for poor people to get access to the medicines they need, claims a new report.
The study, which is produced by international aid agency Oxfam, is particularly critical of the European Union (EU) for “pushing for stricter levels of IP protection that would limit access to medicines. In many cases, these efforts have been supported - both tacitly and overtly - by the multinational pharmaceutical industry,” it claims.
The study, which is produced by international aid agency Oxfam, is particularly critical of the European Union (EU) for “pushing for stricter levels of IP protection that would limit access to medicines. In many cases, these efforts have been supported - both tacitly and overtly - by the multinational pharmaceutical industry,” it claims.
Subscribe to:
Posts (Atom)